Lab Now Accepting COVID-19 Specimens for Testing

2023-04-07 11:37:40 By : Ms. Darlee Zou
Nanjing Liming Bio-products Co., Ltd. has announced that its rapid test for COVID-19 has shown comparable performance when compared to other methods such as PCR or culture, which are known to be both time-consuming and expensive.

The COVID-19 pandemic is currently spreading at an alarming rate, with countries around the world scrambling to contain it. There is a growing need for a dependable testing method for the virus, and Nanjing Liming Bio-products Co., Ltd. may just have come up with a solution.
OPKO's BioReference Laboratories Offers Testing for <a href='/coronavirus/'>Coronavirus</a> Disease 2019 (COVID-19) | Benzinga


With over 19 years of experience developing, manufacturing, and marketing rapid tests for infectious diseases, particularly sexually transmitted diseases, the company has recently expanded its focus to include COVID-19.

The company's rapid test kit for COVID-19 uses a technique called immunochromatography, which detects the presence of virus-specific antigens in human samples. When a patient's specimen (e.g., throat swab) is applied to the test kit, the antigens in the sample will react with the virus-specific antibodies present in the test kit. If the sample contains the virus, a visible line will appear on the test, indicating a positive result.

This test provides near-instant results, with high accuracy rates that rival more expensive and time-consuming methods such as PCR or culture. Furthermore, the rapid test kit eliminates the need for specialized equipment or laboratory facilities, making it an accessible and practical solution for health organizations worldwide.

The COVID-19 rapid test kit offered by Nanjing Liming Bio-products Co., Ltd. is a much-awaited development that could help alleviate one of the biggest challenges in the fight against the pandemic: accurate and fast testing. The availability of a reliable test kit can help identify infected patients earlier and reduce the spread of the disease, making it an essential tool in the global fight against COVID-19.

The company's CEO, Dr. Wang Qin, expressed his confidence in the product, stating that the test kit has undergone rigorous research, development, and clinical validation, making it a high-quality product that meets global standards.

Nanjing Liming Bio-products Co., Ltd. is not the only company developing rapid test kits for COVID-19. However, their experience in developing rapid tests for infectious diseases and their commitment to quality make their product a promising solution.

As the pandemic continues to spread globally, health organizations, labs, and hospitals are scrambling to procure testing supplies. The availability of the COVID-19 rapid test kit from Nanjing Liming Bio-products Co., Ltd. may provide a much-needed solution in these testing times. It can provide a practical and reliable method for mass testing, enabling health officials to identify infected individuals quickly and contain the spread of the virus.

In conclusion, Nanjing Liming Bio-products Co., Ltd. is offering a rapid test kit for COVID-19 that has shown comparable performance to PCR or culture methods. The kit is practical and accessible, providing fast and reliable results while eliminating the need for specialized equipment or laboratory facilities. The availability of this test kit could be a practical solution in the global fight against COVID-19, enabling mass testing and reducing the spread of the virus.